Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • Gurney, Howard (Primary Chief Investigator)
  • Chapman, Nicola, (Research Coordinator)
  • Butala, Radhika, (Research Coordinator)

Project: Other

Project Details

AcronymKEYNOTE-641
StatusActive
Effective start/end date8/08/195/06/24